Ocrevus (ocrelizumab): Risk för leverskada – nya rekommendationer om övervakning av leverfunktionen

Läkemedelsverket Version 1 original current

Imported from official source

Information till hälso- och sjukvården – DHPC.

This version

Version
1 of 1
Recorded
October 08, 2026 10:35
Change
Initial
Content hash
f720fa2f861d08768b64737fae88da52
All versions
Revision history

Officially records where a publication came from, not whether it is true. Imported records are reproduced from an organization's own official source.